Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pazopanib and Interferon Alfa 2-A in Advanced Renal Cell Carcinoma
NCT01513187Phase 2Completed
- Sponsor
- SOGUG
- Start
- Jul 2011
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pazopanib in renal cell carcinoma (RCC), sponsored by SOGUG. Started Jul 2011; status: completed.
02
Drugs
pazopanib
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT01513187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01513187.